Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Izzo

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 22, 2008
Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiationJ G Izzo, X Wu, T-T Wu, et al.
Gastrointestinal Cancer Research : GCR|April 11, 2009
Emerging molecular targets in esophageal cancersJulie G Izzo, Rajyalakshmi Luthra, Jennifer Sims-Mourtada, et al.
Molecular Cancer Therapeutics|November 24, 2006
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinomaJulie G Izzo, Arlene M Correa, Tsung-Teh Wu, et al.
Cancer|July 16, 2008
Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagusHeta Javeri, Rohan Arora, Arlene M Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2006
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinomaJulie G Izzo, Usha Malhotra, Tsung-Teh Wu, et al.
Cancer|July 20, 2007
Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancerPooja R Patel, Paul F Mansfield, Christopher H Crane, et al.
Journal of the National Cancer Institute|February 6, 2003
Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancerJulie G Izzo, Vassiliki A Papadimitrakopoulou, Diane D Liu, et al.
Cancer Research|April 19, 2006
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic krasMarie Wislez, Nobukazu Fujimoto, Julie G Izzo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cyclin D1 and cancer development in laryngeal premalignancy patientsVassiliki Papadimitrakopoulou, Julie G Izzo, Diane D Liu, et al.
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 22, 2008
Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiationJ G Izzo, X Wu, T-T Wu, et al.
Gastrointestinal Cancer Research : GCR|April 11, 2009
Emerging molecular targets in esophageal cancersJulie G Izzo, Rajyalakshmi Luthra, Jennifer Sims-Mourtada, et al.
Molecular Cancer Therapeutics|November 24, 2006
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinomaJulie G Izzo, Arlene M Correa, Tsung-Teh Wu, et al.
Cancer|July 16, 2008
Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagusHeta Javeri, Rohan Arora, Arlene M Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2006
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinomaJulie G Izzo, Usha Malhotra, Tsung-Teh Wu, et al.
Cancer|July 20, 2007
Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancerPooja R Patel, Paul F Mansfield, Christopher H Crane, et al.
Journal of the National Cancer Institute|February 6, 2003
Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancerJulie G Izzo, Vassiliki A Papadimitrakopoulou, Diane D Liu, et al.
Cancer Research|April 19, 2006
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic krasMarie Wislez, Nobukazu Fujimoto, Julie G Izzo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cyclin D1 and cancer development in laryngeal premalignancy patientsVassiliki Papadimitrakopoulou, Julie G Izzo, Diane D Liu, et al.
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
Pageof 12